Ildiko Lingvay
Professor of Internal Medicine · University of Texas Southwestern Medical Center
Credentials: · · · ·
History
- 1994–1998
Carol Davila University of Medicine & Pharmacy
Research
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
New England Journal of Medicine · 2016 · 5,096 citations
Once-Weekly Semaglutide in Adults with Overweight or Obesity
New England Journal of Medicine · 2021 · 3,798 citations
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
New England Journal of Medicine · 2023 · 2,447 citations
- AL
24 papers
- JR
18 papers
17 papers
17 papers
- VA
17 papers
16 papers
13 papers
11 papers
Grants
- 2007–2012
Role of Pancreatic Triglycerides in Beta-Cell Dysfunction
National Center for Research Resources · K23
Contact PI · $755K · Ut Southwestern Medical Center
Clinical trials
- 2027–2029
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
Principal investigator · Not yet recruiting
Boston Scientific Corporation
- 2023–2028
Principal investigator · Active not recruiting · Phase 4
University of Texas Southwestern Medical Center
- 2014–2017
Principal investigator · Completed · Phase 4
University of Texas Southwestern Medical Center
- 2012–2016
Adding Liraglutide to High Dose Insulin: Breaking the Cycle
Principal investigator · Completed · Phase 4
Ildiko Lingvay